Scolaris Content Display Scolaris Content Display

Emtricitabine for adults with lamivudine‐resistant chronic hepatitis B virus infection

This is not the most recent version

Appendices

Appendix 1. Search Strategy

Database

Time span

Search strategy

Cochrane Hepato‐Biliary Group Controlled Trials Register

Date will be given at review stage.

lamivudin* AND resistan* AND (chronic AND (hepatitis B OR hep B OR HBV))

Cochrane Central Register of Controlled Trials (CENTRAL)

Latest issue

#1 MeSH descriptor: [Lamivudine] explode all trees

#2 lamivudine

#3 #1 or #2

#4 resistan*

#5 MeSH descriptor: [Hepatitis B, Chronic] explode all trees

#6 (chronic and ('hepatitis B' or 'hep B' or HBV))

#7 #5 or #6

#8 #3 and #4 and #7

MEDLINE (Ovid SP)

1946 to the date of search.

1. exp Lamivudine/

2. lamivudine.mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier]

3. 1 or 2

4. resistan*.mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier]

5. exp Hepatitis B, Chronic/

6. (chronic and ('hepatitis B' or 'hep B' or HBV)).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier]

7. 5 or 6

8. 3 and 4 and 7

9. (random* or blind* or placebo* or meta‐analys*).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier]

10. 8 and 9

Embase (Ovid SP)

1974 to the date of search.

1. exp lamivudine/

2. lamivudine.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword]

3. 1 or 2

4. resistan*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword]

5. exp hepatitis B/

6. (chronic and ('hepatitis B' or 'hep B' or HBV)).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword]

7. 5 or 6

8. 3 and 4 and 7

9. (random* or blind* or placebo* or meta‐analys*).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword]

10. 8 and 9

Science Citation Index Expanded (Web of Science)

1900 to the date of search.

#6 #5 AND #4

#5 TS=(random* or blind* or placebo* or meta‐analys*)

#4 #3 AND #2 AND #1

#3 TS=(chronic and ('hepatitis B' or 'hep B' or HBV))

#2 TS=(resistan*)

#1 TS=(lamivudine)